Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
Evvy
Evvy Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Do published findings about Evvy match what happens in practice?
Still openWhether the reported magnitude holds in practice, and in which specialties it does not.
Public evidence
Evvy Launches AI Advisor to Decode Vaginal Dysbiosis and Biomarkers
HIT Consultant
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 1 public external signal(s) across 1 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands Evvy through regulatory records and external market activity.
- Category
- womens-health
What HealthAratus is still learning
HealthAratus is beginning to understand Evvy. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
Evvy is an at-home vaginal microbiome test that uses metagenomic sequencing to identify bacteria and fungi. The platform provides insights into vaginal health and connects users with personalized care plans.
Stated capabilities
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
The test provides insights into the vaginal microbiome to inform patient treatment plans.
According to Evvy
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported outcome
Evvy Launches AI Advisor to Decode Vaginal Dysbiosis and Biomarkers
According to HIT Consultant
Are you seeing this result?
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
• Evvy offers comprehensive at-home vaginal health solutions: a CLIA-, CAP-, and CLEP-certified metagenomic sequencing test analyzing over 700 bacteria and fungi from a single swab sample. This test provides insights into vaginal health, fertility markers, and connections to symptoms or hormonal changes. Results are…
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in home settings, US
Key strength
Regulatory: CLIA-certified, CAP-certified, CLEP-certified
Key capabilities
Comprehensive metagenomic sequencing analyzing over 700 bacteria and fungi, Clinician-reviewed results with personalized action plans, Optional Expanded PCR Panel for STI testing and antibiotic resistance detection
Clinical use cases
Diagnosis and treatment of bacterial vaginosis (BV), Management of recurrent yeast infections, Assessment of fertility-related vaginal microbiome factors
Who uses it
Individuals experiencing recurrent vaginal symptoms, Those interested in fertility optimization, Individuals undergoing menopause
How the reality here has changed
Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of Evvy accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.
Connected intelligence
Category intelligence